| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.96▼ | 2.99▼ | 2.99▼ | 3.16▼ | 3.00▼ |
| MA10 | 2.97▼ | 3.00▼ | 3.05▼ | 3.13▼ | 3.30▼ |
| MA20 | 2.99▼ | 3.08▼ | 3.15▼ | 3.02▼ | 2.87▲ |
| MA50 | 3.00▼ | 3.17▼ | 3.20▼ | 3.39▼ | 2.45▲ |
| MA100 | 3.07▼ | 3.19▼ | 3.13▼ | 2.89▲ | 11.66▼ |
| MA200 | 3.16▼ | 3.10▼ | 3.03▼ | 2.44▲ | 19.21▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.009▼ | -0.026▼ | 0.016▲ | 0.118▲ |
| RSI | 18.069▼ | 20.920▼ | 22.461▼ | 44.330▼ | 46.959▼ |
| STOCH | 4.722▼ | 10.504▼ | 5.601▼ | 51.304 | 23.865 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -86.667▼ | -69.728 |
| CCI | -135.581▼ | -112.310▼ | -118.077▼ | -75.427 | -18.473 |
|
Wednesday, December 03, 2025 05:38 AM
Cassava Sciences (NASDAQ:SAVA) slid 13% in early Monday trading after the company disclosed that the U.S. Food and Drug Administration has asked for more information related to its investigational new ...
|
|
Monday, September 29, 2025 05:00 PM
Fintel reports that on October 6, 2025, LUCID CAPITAL MARKETS initiated coverage of Cassava Sciences (NasdaqCM:SAVA) with a Buy recommendation. As of September 30, 2025, the average one-year price ...
|
|
Monday, April 21, 2025 01:41 PM
The appointment of Dr. Jack Moore as Senior Vice President, Clinical Development brings extensive experience in CNS drug development, which could enhance the company’s initiatives for simufilam and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/12/25 | 3.16 | 3.20 | 2.93 | 2.93 | 852,924 |
| 11/12/25 | 3.23 | 3.32 | 3.14 | 3.15 | 642,200 |
| 10/12/25 | 3.23 | 3.29 | 3.19 | 3.26 | 564,200 |
| 09/12/25 | 3.20 | 3.28 | 3.15 | 3.24 | 664,200 |
| 08/12/25 | 3.19 | 3.26 | 3.13 | 3.20 | 497,700 |
| 05/12/25 | 3.30 | 3.38 | 3.15 | 3.19 | 860,500 |
| 04/12/25 | 3.09 | 3.35 | 3.06 | 3.32 | 1,085,800 |
| 03/12/25 | 2.92 | 3.11 | 2.90 | 3.10 | 713,500 |
| 02/12/25 | 3.04 | 3.07 | 2.88 | 2.89 | 803,700 |
| 01/12/25 | 3.21 | 3.23 | 3.01 | 3.03 | 860,800 |
|
|
||||
|
|
||||
|
|